Story perspectives
NK Cell Therapy Report: 160 Innovations Transforming Cancer Treatment
9/4/2025
50 4
1 of 1
Story summary
- The NK Cell Therapy pipeline report evaluates over 140 active companies and 160 therapies at various development stages.
- Key players include Amgen, ImmunityBio, and Takeda, targeting innovative cancer and rheumatologic disease treatments.
- Notable therapies in clinical trials include AlloNK® and KUR-501.
- The report highlights the effectiveness of allogeneic NK cell therapies from umbilical cord blood.
